Yili Xu

机构：Yanshan University, Gilead Sciences (United States), Jiangsu Province Hospital, Virtual Technology (United States), Nanjing Medical University · ORCID：0000-0002-0083-799X

发表论文 76 篇 · 总被引 4604 次 · h-index 24

代表论文

• Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys (2023 · Journal of Medicinal Chemistry · 被引 63)
• CHAC1 as a Novel Contributor of Ferroptosis in Retinal Pigment Epithelial Cells with Oxidative Damage (2023 · International Journal of Molecular Sciences · 被引 54)
• Acute and continuous exposure of airborne fine particulate matter (PM2.5): diverse outer blood–retinal barrier damages and disease susceptibilities (2023 · Particle and Fibre Toxicology · 被引 32)
• Long-term PM2.5 exposure disrupts corneal epithelial homeostasis by impairing limbal stem/progenitor cells in humans and rat models (2023 · Particle and Fibre Toxicology · 被引 29)
• Discovery of GS-7682, a Novel 4′-Cyano-Modified C -Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys (2024 · Journal of Medicinal Chemistry · 被引 17)
• Ferroptosis is involved in the damage of ocular lens under long-term PM2.5 exposure in rat models and humans (2024 · Ecotoxicology and Environmental Safety · 被引 11)